Isabelle Ray-Coquard

No ORCID on file · 5 papers in corpus
other 2026
Gynecologic Oncology ·doi:10.1016/j.ygyno.2026.05.029
meta-analysis 2026
Gynecologic Oncology ·doi:10.1016/j.ygyno.2026.05.004

OBJECTIVE: To critically evaluate the evidence linking endometriosis to ovarian cancer, with particular focus on endometrioid and clear cell histologic subtypes, and to inform risk stratification and patient counseling. METHODS: A systemat…

observational 2023
Journal of translational medicine ·doi:10.1186/s12967-023-04264-7

BACKGROUND: Uterine clear cell carcinomas (CCC) represent less than 5% of uterine cancers. Their biological characteristics and clinical management remain uncertain. A multicenter study to explore both clinical and molecular features of the…

review 2023
Current opinion in obstetrics & gynecology ·doi:10.1097/gco.0000000000000836

PURPOSE OF REVIEW: In spite of their rarity when considered individually, the sum of all rare ovarian tumours (ROT) represent almost half of all ovarian malignancies. As such, their appropriate inclusion within dedicated clinical trials is …

observational 2022
Annals of surgical oncology ·doi:10.1245/s10434-022-12353-y

BACKGROUND: The term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical…